1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 4:Imaging features in patients with infection, sepsis, and shock
Pt # Imaging Locations of PRES Vasogenic Edema MRA Imaging Modality DWI F/U Imaging Clinical at Discharge Edema Grade MAP C T O P F Misc Group1 1 x x x MR n/o Resolved 3 86 2 Spasm-imp MR Neg Res 2 78 3 x x x x MR Neg Resolving Resolved 5 87 4 x x x x x t Pruning MR n/o Resolved 5 104 5 x x x x CT Res 3 98 6 x CT Expired 2 106 7 Pruning MR Neg Resolving Resolved 2 101 8 x x x x CT Res 5 104 9 x x x x Normal MR Neg Res 2 93 10 x x x MR Neg* Resolving Resolved 4 85 Group 2 11 x x x x t mb Spasm/prun MR Neg Normal 2 138 12 x x x x MR Neg Res 3 140 13 x x x x x bs mb c MR Neg Res 1 133 14 x x x x x bs MR Neg Res 3 135 15 x x x x CT Resolved 1 126 16 x x x CT Expired 2 123 17 x x x t Spasm MR Neg Resolving Resolved 2 148 18 x x x x Spasm MR Neg Resolving Resolved 3 129 19 x x x Spasm-rev MR Neg Res 1 133 20 x x x x bs MR Neg Resolving Resolved 2 141 21 x x MR Neg — Resolved 1 157 22 x x x x Spasm MR Neg Res 4 130 23 x x x x MR Neg Res 1 143 24 x x x x Spasm-rev MR Neg* Res* 3 143 25 x x x x MR n/o Res 2 140
Note:—PRES indicates posterior reversible encephalopathy syndrome; C, cerebellum; T, temporal lobe/inferior temporal-occipital junction; O, occipital lobe; P, parietal region; F, frontal lobes; bs, brain stem including medulla and pons; mb, midbrain; t, thalamus; c, caudate nucleus; rev, spasm reverses; imp, spasm improves; spasm/prun, middle crebral artery spasm with posterior cerebral artery pruning; DWI, diffusion-weighted image characteristics; n/o, DWI not obtained with MR imaging study; Neg, no evidence of restricted diffusion to suggest cytotoxic edema; Neg*, no restricted diffusion in the majority of vasogennic edema with focal region of restricted diffusion and hemorrhage noted; Res, vasogenic edema completely resolved on follow-up imaging studies; Res*, vasogenic edema resolved with minor persistent abnormal signal in region of previously noted restricted diffusion, infarction, or focal hemorrhage; Resolving, resolving vasogenic edema on follow-up imaging studies or resolving clinical symptoms related to PRES; Resolved, clinical symptoms at PRES neurotoxicity resolved; MAP, mean arterial pressure.